Dow Up 1.32% Nasdaq Up 1.60%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.02 0.03(2.86%) Oct 23, 4:00PM EDT
Prev Close:1.05
Open:1.04
Bid:1.02 x 6100
Ask:1.03 x 100
1y Target Est:1.67
Beta:0.88
Next Earnings Date:N/A
Day's Range:1.02 - 1.08
52wk Range:0.85 - 2.35
Volume:138,698
Avg Vol (3m):360,002
Market Cap:52.80M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVEO

Comparison

Symbol% ChgMkt Cap
AVEODown 2.86%52.80M
AMGN111.85B
PFE181.35B
RHHBY249.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.92
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback